Aura in Cluster Headache: A Cross‐Sectional Study

Background Aura symptoms have been reported in up to 23% of cluster headache patients, but it is not known whether clinical characteristics are different in participants with and without aura. Methods Using validated web‐based questionnaires we assessed the presence and characteristics of attack‐rel...

Full description

Saved in:
Bibliographic Details
Published inHeadache Vol. 58; no. 8; pp. 1203 - 1210
Main Authors Coo, Ilse F., Wilbrink, Leopoldine A., Ie, Gaby D., Haan, Joost, Ferrari, Michel D.
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.09.2018
John Wiley and Sons Inc
Subjects
Alcohols
aura
cluster headache
Clusters
Cross-sectional studies
epidemiology
Headache
headache characteristics
Headaches
LUCA study
Pain
Research Submissions
LUCA study
epidemiology
headache characteristics
aura
cluster headache
Online AccessGet full text
ISSN0017-8748
1526-4610
1526-4610
DOI10.1111/head.13344

Cover

More Information
Summary:Background Aura symptoms have been reported in up to 23% of cluster headache patients, but it is not known whether clinical characteristics are different in participants with and without aura. Methods Using validated web‐based questionnaires we assessed the presence and characteristics of attack‐related aura and other clinical features in 629 subjects available for analysis from an initial cohort of 756 cluster headache subjects. Participants who screened positive for aura were contacted by telephone for confirmation of the ICHD‐III criteria for aura. Results Typical aura symptoms before or during cluster headache attacks were found in 44/629 participants (7.0%) mainly involving visual symptoms (61.4%). Except for lower alcohol consumption and higher prevalence of frontal pain in participants with aura, no differences in clinical characteristics were found compared with participants without aura. Conclusion At least 7.0% of the participants with cluster headache in our large cohort reported typical aura symptoms, which most often involved visual symptoms. No major clinical differences were found between participants with and without aura.
Bibliography:M.D. Ferrari reports grants and consultancy or industry support from Medtronic, Amgen, Lilly, and Electrocore, and independent support from NWO, ZonMW, NIH, European Community, Dutch Heart Foundation, and Fonds Nuts Ohra (to M.D. Ferrari and L.A. Wilbrink). This study was supported by grants from the Netherlands Organisation for Scientific Research (NWO) and the European Union's Seventh Framework programme (2007–2013) under grant agreement no. 602633 to MDF. I.F. de Coo reports support for conference visits from Electrocore. L.A. Wilbrink and J. Haan report no conflict of interest.
Conflict of Interest
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Conflict of Interest: M.D. Ferrari reports grants and consultancy or industry support from Medtronic, Amgen, Lilly, and Electrocore, and independent support from NWO, ZonMW, NIH, European Community, Dutch Heart Foundation, and Fonds Nuts Ohra (to M.D. Ferrari and L.A. Wilbrink). This study was supported by grants from the Netherlands Organisation for Scientific Research (NWO) and the European Union's Seventh Framework programme (2007–2013) under grant agreement no. 602633 to MDF. I.F. de Coo reports support for conference visits from Electrocore. L.A. Wilbrink and J. Haan report no conflict of interest.
ISSN:0017-8748
1526-4610
1526-4610
DOI:10.1111/head.13344